conclusions blacks had poorer HTN control compared with whites and Hispanics. Significant discrepancies in bP control between hypertensive patients with and without diabetes may be related to a lack of provider adherence to JNc 7 guidelines that define bP control in this population as <130/80. Further research is needed to understand racial disparities in bP control as well as factors influencing clinician's management of bP among patients with diabetes.
Ethnic disparities in awareness, treatment, and control of hypertension (HTN) have been consistently documented in the National Health and Nutrition Examination Survey (NHANES), which has tracked this information since the 1960s. [1] [2] [3] [4] A recently updated analysis of NHANES reported an improvement in blood pressure (BP) control across all race/ ethnicities between 1988-1994 and 2007-2008 , but significant disparities persist. 5 In 2007-2008, the proportion of patients whose HTN was treated and controlled remained significantly higher in whites compared with blacks and Hispanics. 5 The updated NHANES data suggested that reducing disparities in BP control would require improving the effectiveness of treatment among blacks, and among Hispanic individuals, emphasizing screening and referral to a primary care medical home. However, uncontrolled HTN often occurs in populations with regular access to health care, and there is evidence that racial disparities exist even at the practice level. 6, 7 For example, Hicks and colleagues found that, even when accounting for frequency of clinic visits and prevalence of diabetes, blacks and whites were more likely than Hispanics to have their HTN therapy intensified appropriately by their physician or health-care provider. 7 Most data on correlates of controlled HTN are derived from national data sets. 2, 3, 5 Among the studies that have examined HTN control in primary care settings, few have included minority populations or been conducted in federally qualified community health centers (FQHCs) which reach the most vulnerable populations. 6, [8] [9] [10] As a result, the prevalence of HTN and correlates of HTN control among low income, minority, and/or immigrant populations who access care in FQHCs is poorly characterized. This study takes advantage of a large office-based dataset derived from four FQHCs to describe the prevalence and correlates of HTN control in an ethnically diverse, low-income population who have regular access to primary care.
Methods
Setting and study population. We created a database from electronic medical records for all adult, nonobstetric patients
Background
The correlates of blood pressure (bP) control among hypertensive individuals who have access to care in community-based health-care settings are poorly characterized, particularly among minority and immigrant populations.
Methods
Using data extracted from electronic medical records in four federally qualified health centers in New York, we investigated correlates of hypertension (HTN) control in cross-sectional analyses. The sample consisted of adult, nonobstetric patients with a diagnosis of HTN and a clinic visit between June 2007 and October 2008 (n = 2,585).
results
Forty-nine percent of hypertensive patients had controlled bP at their last visit. blacks had a higher prevalence of HTN (b, 32.8%; W, 16.2%; H, 11.5%) and were less likely to have controlled bP (b, 42.2%; W, 50.9%; H, 50.8%) compared with Hispanics and whites. medication intensification did not differ by race/ethnicity. In multivariate analyses higher body mass index (bmI), black race, diabetes, fewer clinical encounters, and male gender were associated with poor bP control. However, when we applied the Seventh report of the Joint National committee (JNc 7) definition for bP control for nondiabetic patients (systolic blood pressure (SbP) <140, diastolic blood pressure (dbP) <90) to all patients with HTN, we found no difference in bP control between those with and without diabetes. Measures. Using the Seventh Report of the Joint National Committee (JNC 7) classification, controlled HTN was defined as systolic blood pressure (SBP) <140 and diastolic blood pressure (DBP) <90. For patients with a diagnosis of diabetes, controlled HTN was defined as SBP <130 and DBP <80. 11 Also, according to JNC 7 guidelines, stage 2 hypertension was defined as SBP ≥160 or DBP ≥100. We used the last visit during the study period to assess BP control. Additional variables that were extracted from the EMR were chosen a priori based on review of the literature and JNC 7 guidelines in collaboration with Open Door's study team (i.e., chief medical officer, nurse administrator, executive director, and a physician representative from the performance improvement committee), and the New York City Department of Health and Mental Hygiene which developed five quality indicators using data from the eCW system (e.g., annual body mass index (BMI), electrocardiogram and lipid profile, and visit with nutritionist, and appropriate intervals for follow-up visits if BP out of normal range).
To assess clinical inertia, the term generally used to describe the failure of clinicians to initiate or intensify antihypertensive therapy despite elevated BP levels, 12 we assessed the percentage of visits in which medications were started or changed when the BP was elevated. For the purposes of this article, we refer to this variable as medication intensification. Finally, we assessed the percentage of patients with undiagnosed HTN defined as those patients with two or more visits with a documented elevated SBP or DBP but no ICD code in the chart documenting a diagnosis of HTN. For this analysis, the denominator was patients with at least two visits during the study period (n = 11,833).
Data abstraction. Access to encounter-or patient-level data is not readily available through eCW. Accordingly, a process was developed to extract encounter-level data from eCW's back-end database to create a new data file for analysis. Data from eCW's back-end tables were extracted using BridgeIT, a data management utility that maps Open Door's EMR data into easily accessed and queried Microsoft Access software (Microsoft, Redmond, WA). On a nightly basis, the eCW raw data are extracted, loaded, transformed via BridgeIT and saved in Open Door's stand-alone data warehouse which was created for the purpose of this study. Study variables were extracted from the data warehouse for each patient encounter, saved in an excel file, and transmitted securely to the data coordinating center at Columbia University.
BP measurement quality assurance. To ensure accuracy and validity of BP measurement and recording in the EMR (in addition to avoiding misdiagnosis), a retraining of nursing staff was undertaken in November 2007 using an online tutorial available at <http://www.abdn.ac.uk/medical/bhs/index. htm>. Nurses were taught that the operational definition of SBP was the first sound heard, with care not to measure after the auscultatory gap. The definition of DBP was when sound ceased to be heard. 13 Statistical analyses. Patients with at least one visit between June 2007 and October 2008 were included in the analysis. Data analyses consisted of three parts. First, an analysis of variance test and χ 2 analysis were conducted to compare the distribution of patient characteristics among black, white, and Hispanic ethnicities. Next, the association between each potential predictor variable and uncontrolled HTN was examined using analysis of variance test for continuous variables, Fisher's exact test for binary variables, and χ 2 analysis for other categorical data. Finally, variables which showed correlations with the outcome at a significance level of 0.1 were entered into a logistic regression model to predict uncontrolled HTN. All analyses were performed with SPSS software (Statistical Program for Social Sciences; IBM, Armonk, NY) for Windows. This study was approved by the New York University and Columbia University institutional review committees.

Prevalence of htn
In order to assess prevalence, the predetermined variables were abstracted from all patients ≥18 years (n = 18,996) who had a visit with a primary care provider between June 2007 and October 2008. Among the total patient population, 14% (2,712) had a diagnosis of HTN. The HTN rate among blacks (32.8%) was more than twice the rates for whites (16.2%) and Hispanics (11.5%). Among all patients who had at least two visits during the study period (n = 11,833), 548 (4.6%) had undiagnosed HTN. Hispanics were less likely than whites or blacks (P < 0.001, data not shown) to fall into this category. .7) were significantly higher among blacks compared with whites (mean SBP 135.5 and DBP 82.0) and Hispanics (mean SBP 135.6 and DBP 82.5). Medication intensification (i.e., percent visits with change in medication when BP elevated at last visit) did not differ significantly by race/ethnicity. There were also no racial/ethnic differences in additional quality indicators (data not shown) (e.g., percent patients who had a lipid level evaluated in the past 12 months).
correlates of uncontrolled htn
At the last visit during the study period, 1,308 hypertensive patients (51.0%) had uncontrolled BP. As shown in Table 2 , uncontrolled HTN was associated with male gender, race/ ethnicity, income, fewer clinical encounters, higher BMI, and a greater number of prescribed medications. Among patients with documentation of three or more prescribed medications, 56% had uncontrolled BP compared with 50.3% of those with one medication and 45.3% of those with no documented medications at the last visit. Blacks were significantly less likely to have their BP controlled (42.2%) compared with whites (50.9%) and Hispanics (50.8%). BP control did not vary by age or whether or not a patient visited a nutritionist.
Patients with diabetes were significantly less likely to have controlled BP (29.6%) (defined as SBP <130 and DBP <80) compared with hypertensive patients who did not have diabetes (56.9%). Patients with diabetes were significantly less likely to have their medication changed or increased when their BP was uncontrolled than patients without diabetes (20.5% of visits with abnormal BP vs. 30.6%, P < 0.001, data not shown in tabular form). When we calculated the rate of BP control using the same JNC 7 definition of controlled BP for patients with diabetes as we did for nondiabetic patients, the difference in rates of BP control was no longer significant. Using SBP <140 and DBP <90 as the cut off, the rate of BP control for patients with diabetes was 61.6%.
logistic regression
Results of the logistic regression analysis are shown in Table 3 . Blacks were more likely to have uncontrolled HTN compared with whites (blacks vs. whites: odds ratio (OR) = 1.36, P = 0.006). There was no difference in rates of BP control between whites and Hispanics. The odds of uncontrolled HTN were lower for females (OR = 0.74, P = 0.006). Patients who Values are means with standard deviations or frequencies with percentages. ANOVA tests were conducted for continuous variables and χ 2 analysis was used for categorical variables. Missing rates were negligible or 0 for all variables. ANOVA, analysis of variance; BMI, body mass index; BP, blood pressure; DBP, diastolic blood pressure; SBP, systolic blood pressure. a Percent within each ethnicity is shown in parentheses. b Stage 2 hypertension (SBP ≥160 or DBP ≥100) was determined based on patients' blood pressure readings at their first visit during the baseline study period. *P < 0.05; **P < 0.01; ***P < 0.001; † P < 0.1. 5, 14 Similar to findings in previous studies, we found that blacks had a higher prevalence of HTN and were less likely to have controlled HTN compared with whites and Hispanics. 1, 5, 15, 16 Hispanics were as likely as whites, to have controlled BP. 7 In contrast to our findings, in another study conducted in an ambulatory care setting that included a large Hispanic population, Hicks and colleagues found that Hispanics were less likely to have controlled BP compared with other race/ethnic groups. Several differences between the studies may explain the discrepancy. Hicks and colleagues studied patients from community health centers affiliated with a large urban academic medical center, whereas Open Door's FQHCs are freestanding clinics located in the suburbs of New York City, and the proportion of Hispanic patients was much larger in Open Door (80% of patients). Hicks' study was conducted in 2001, one year before the release of JNC 7 guidelines; therefore our findings may reflect practice patterns that have changed over time. In addition, we included patients who were not on medication in this analysis. Hispanics were more likely than the other racial/ethnic groups to be in this category.
National surveys have consistently found lower rates of treatment among Hispanics compared with black and whites. 1, [3] [4] [5] 10 This finding has been interpreted as evidence of disparities in treatment and has raised concerns that care agencies have failed to reach this growing segment of the population. This explains the discrepancy in total number of patients in table 1 and 2. Missing rates were negligible or 0 for all variables in table 2. *P < 0.01; **P < 0.001; ***P < 0.1.
original contributions
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However, the 2007-2008 analysis of NHANES did not find differences in BP control between blacks and Hispanics despite blacks being more likely to receive treatment. 5 Similarly, we found that Hispanics with a diagnosis of HTN and regular access to care were less likely to have medication prescribed and those treated were prescribed fewer medications compared with blacks, but this was not associated with poorer BP control. Among blacks, higher rates of medication use and a higher percentage receiving three or more medications compared with whites and Hispanics is consistent with recent recommendations from the updated International Society on Hypertension in blacks consensus statement which de-emphasizes monotherapy in this population. 17 Few studies have tried to assess the processes that mediate reported ethnic/racial disparities in BP control. 10, [18] [19] [20] Drawing on data extracted from EMRs, Hicks found that among patients receiving medication, Hispanics were least likely to have medication altered compared with blacks and whites. 7 However, in a subsequent analysis these discrepancies were largely accounted for by differences in frequency of clinic visits and prevalence of diabetes. 10 Umscheid and colleagues also found that although blacks had higher unadjusted odds of uncontrolled HTN compared with white patients, providers were more likely to intensify antihypertensive drugs at visits of blacks compared with white patients, as appropriate. 21 Consistent with Hicks and Umscheid, we found no racial differences in rates of medication intensification, but patients with diabetes were significantly less likely to have medication changed when their BP was abnormal compared with patients without diabetes. Diabetes was also a predictor of poor BP control.
Diabetes has been consistently associated with reduced odds of BP control 2, 10, 18 Patient level factors, such as compliance with a more complex medical regimen, may explain discrepancies in HTN control between diabetic and nondiabetic patients in this and other studies; however, provider level factors may also contribute to the discrepancy. [21] [22] [23] For example, attitudes, and therefore practice patterns, related to HTN management may be impacted by inconsistencies in the literature regarding the beneficial effect of intensive BP control on progression of disease. 24 In addition, when treating diabetics with HTN, providers balance clinical circumstances and issues of polypharmacy and cost when deciding whether to start or alter the medication regimen. 19 It is notable that when we analyzed BP control using the JNC 7 definition for the general population (i.e., <140/90) we found no association between BP control and a diagnosis of diabetes. This is consistent with our findings that clinicians were less likely to change BP medications in uncontrolled diabetics and were therefore not necessarily using the lower JNC 7 recommended threshold for defining elevated BP for patients with diabetes. Before collecting the data for this analysis, we conducted a survey that suggested that providers at Open Door were familiar with the guidelines; however, previous research has shown that knowledge is not necessarily associated with recommended practice. [21] [22] [23] 25 Cook found that although providers reported BP goals that were more stringent than the JNC guidelines for several clinical scenarios, they were least likely to agree with JNC BP targets set for patients with diabetes. 21 Similarly, Wexler et al. found that 50% of physicians would not intervene at recommended levels even if the patient had concomitant comorbidities including diabetes. 23 Additional research is needed to explore factors that influence treatment decisions, particularly for patients with both HTN and diabetes. 22 Higher rates of BP control were also correlated with a greater number of clinical encounters across racial/ethnic groups, but poorer control among blacks could not be explained by poor access to medical care. Patients averaged six medical clinic visits with a BP measurement during the 18 month study period, and despite slightly fewer visits, Hispanics were more likely to have controlled BP. Previous research has suggested that access to a regular source of health care is associated with control of HTN in the community. 26 For the Hispanic population, in particular, this study demonstrated that access to care in community health centers that were established to serve a growing Hispanic immigrant community can achieve national goals for BP control. Open Door's staff, including providers, is largely bilingual which may have impacted the outcomes. Numerous studies have found that communication barriers can adversely affect health outcomes. [27] [28] [29] [30] Effective patient-provider communication and agreement about treatment are associated with improved treatment adherence, self-management skills, and enhanced health outcomes. Access to concordant language services, therefore, may be one explanation for the higher rates of BP control among Hispanics than previously reported. Beyond language concordance, Open Door has several policies and programs that were put in place to overcome cultural barriers in delivering high quality care. These include cultural competency training at orientation and ensuring that at least 50% of the members of Open Door's Board of Directors are patients in one of the four clinics.
Several limitations should be noted. First, we were unable to collect measures of patient adherence to prescribed therapy from EMRs. Information on adherence, which may vary by race/ethnicity, would allow for a better understanding of racial disparities in BP control and variations in treatment decisions made by providers. Second, findings may not be generalizable to smaller rural settings or teaching hospitals, where providers may have strong ties to an academic community. We collected data from patients at four freestanding FQHCs without an affiliation to an academic institution. However, a notable outcome of this study is the demonstration that FQHCs can extract data from an ambulatory care electronic record system to generate large datasets that provide clinical outcome measures that can guide quality improvement. Third, almost a quarter of whites and Hispanics were not receiving any medication at the last visit. This raised questions about the accuracy of the diagnosis of HTN among these patients. However, on further analysis, over 80% of patients did have a medication prescribed at some point during the study period. Moreover, for the patients who were not on any medication and had no elevated BP readings during the data collection period (4.6%)
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Correlates of Controlled Hypertension we reviewed their paper charts and confirmed at least two previously elevated BP measures.
Finally, as this was an effectiveness study, we did not conduct quality checks regarding BP measures. However, during the data collection period there was no staff turnover and staff receive annual competency assessments.
In summary, we found that low-income minority and immigrant populations with access to care in one of four FQHCs in New York had BP control nearing or at the Healthy People 2010 goal of 50%. Additional efforts are needed to continue to improve rates of BP control to reach the revised national 2020 goal of 61%. 30 Although blacks were less likely to have controlled BP, data abstracted from Open Door's EMR did not suggest racial disparities in treatment. We found no racial/ethnic differences in medication intensification, number of encounters, or in Open Door's additional quality indicators such as whether or not a patient had a measure of lipid levels and BMI in the past year. However, there is a need to assess additional patient level (e.g., health literacy and adherence) and provider level factors (e.g., cultural competency) that may contribute to racial disparities in BP control. 17 Our finding that providers may be disregarding JNC 7 guidelines for BP control among patients with diabetes also requires further investigation.
FQHCs offer essential primary health-care services to vulnerable populations and are fundamental to reducing health disparities. Studying implementation of HTN guidelines in these ambulatory care settings is critically important if we are to develop effective strategies for addressing disparities and gaps in translating guideline recommended care into practice.
